Bristol-Myers Q2 Earnings Review: Solid Quarter, But Incoming CMO Must Fix Pipeline

Core Insights - Bristol-Myers Squibb Company (NYSE: BMY) reported Q2 2025 earnings, exceeding market expectations with revenues of $12.3 billion, reflecting a year-on-year increase of approximately 1% [1] - The normalized earnings per share (EPS) for the quarter was reported at $1.46 [1] Financial Performance - Revenues for Q2 2025 reached $12.3 billion, marking a slight increase of around 1% compared to the previous year [1] - The normalized EPS was reported at $1.46, indicating strong performance relative to market forecasts [1]